AMERIPRISE FINANCIAL INC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$948,000
-8.9%
322,473
-15.1%
0.00%
Q4 2017$1,041,000
+2114.9%
379,922
+2623.7%
0.00%
Q3 2017$47,000
-50.5%
13,949
+13.9%
0.00%
Q4 2014$95,000
-20.2%
12,252
-22.8%
0.00%
Q3 2014$119,000
-22.7%
15,871
-0.2%
0.00%
Q2 2014$154,000
+185.2%
15,904
+143.5%
0.00%
Q1 2014$54,000
+50.0%
6,531
+53.3%
0.00%
Q4 2013$36,000
-64.0%
4,260
-66.1%
0.00%
Q3 2013$100,000
+2.0%
12,565
-1.3%
0.00%
Q2 2013$98,00012,7310.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders